Skip Navigation


ToxSci Advance Access originally published online on October 16, 2006
Toxicological Sciences 2007 95(1):182-187; doi:10.1093/toxsci/kfl131
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
95/1/182    most recent
kfl131v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Doostzadeh, J.
Right arrow Articles by Langston, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doostzadeh, J.
Right arrow Articles by Langston, J. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Chemical Genomic Profiling for Identifying Intracellular Targets of Toxicants Producing Parkinson's Disease

Julie Doostzadeh*,1, Ronald W. Davis{dagger}, Guri N. Giaever{dagger},{ddagger}, Corey Nislow{dagger},{ddagger} and James W. Langston*

* The Parkinson's Institute, Sunnyvale, California 94087 {dagger} Stanford Genome Technology Center, California 940304 {ddagger} University of Toronto Donnelley Centre for Cellular and Biomolecular Research, Toronto, Ontario M5S 3E1, Canada

1 To whom correspondence should be addressed at The Parkinson's Institute, 1170 Morse Ave., Sunnyvale, CA 94087. Fax: (408) 734-8522. E-mail: jdoostzadeh{at}thepi.org.

Received June 19, 2006; accepted October 5, 2006


  Abstract

The yeast deletion collection includes ~4700 strains deleted for both copies of every nonessential gene. This collection is a powerful resource for identifying the cellular pathways that functionally interact with drugs. In the present study, the complete pool of ~4700 barcoded homozygous deletion strains of Saccharomyces cerevisiae were surveyed to identify genes/pathways interacting with 1-methyl-4-phenylpyridinium (MPP+) and N,N-dimethyl-4-4-bipiridinium (paraquat), neurotoxicants that can produce Parkinson's disease. Each yeast mutant is molecularly "barcoded" the collections can be grown competitively and ranked for sensitivity by microarray hybridization. Analysis data from these screens allowed us to determine that the multivesicular body pathway is an important element of toxicity induced by both MPP+ and paraquat. When yeast genes that when deleted showed sensitivity to MPP+ and paraquat toxicity were analyzed for their homology to human genes, 80% were found to have highly conserved human homologs (with e < 10–8). Future work will address if these human genes may also functionally interact with MPP+ and paraquat toxicity.

Key Words: chemogenomics; neurotoxicants; Parkinson's disease.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 GeneticsHome page
Z. Yan, N. M. Berbenetz, G. Giaever, and C. Nislow
Precise Gene-Dose Alleles for Chemical Genetics
Genetics, June 1, 2009; 182(2): 623 - 626.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.